3,5-Diiodo-L-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver

Journal of Endocrinology

Volumn 212, Issue 2, 2012, Pages 149-158

  Grasselli, Elena ^a   Voci, Adriana ^a   Demori, Ilaria ^a   Canesi, Laura ^a,e   De Matteis, Rita ^b   Goglia, Fernando ^c   Lanni, Antonia ^d   Gallo, Gabriella ^a   Vergani, Laura ^a,e  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

^c UNIVERSITY OF SANNIO   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A OXIDASE; ADIPOPHILIN; APOLIPOPROTEIN B; DIIODOTHYRONINE; FAT DROPLET; INTERLEUKIN 1BETA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FATTY LIVER; GENE EXPRESSION; GENETIC TRANSCRIPTION; LIPID DIET; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; LIPOLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WEIGHT GAIN;

ACYL-COA OXIDASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOLIPOPROTEINS B; DIIODOTHYRONINES; FATTY LIVER; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPASE; LIPID METABOLISM; LIPOPROTEINS, VLDL; LIVER; MALE; MEMBRANE PROTEINS; MUSCLE PROTEINS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROTEIN ISOFORMS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RNA, MESSENGER; STEAROYL-COA DESATURASE; VESICULAR TRANSPORT PROTEINS;

EID: 84856775058     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0288     Document Type: Article

References (69)

1. Arimura N, Horiba T, Imagawa M, Shimizu M & Sato R 2004 The peroxisome proliferator-activated receptor gamma regulates expression of the perilipin gene in adipocytes. Journal of Biological Chemistry 279 10070-10076
2. Balasubramanian R, Gerrard J, Dalla MC, Firbank MJ, Lane A, English PT, Cobelli C & TaylorR 2010 Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content. Diabetic Medicine 27 150-156
3. Bickel PE, Tansey JT & Welte MA 2009 PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochimica et Biophysica Acta 1791 419-440.
4. Bogacka I, Xie H, Bray GA & Smith SR 2005 Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54 1392-1399
5. Browning JD & Horton JD 2004 Molecular mediators of hepatic steatosis and liver injury. Journal of Clinical Investigation 114 147-152
6. Bustin SA 2010 Why the need for qPCR publication guidelines? - the case for MIQE Methods 50 217-226
7. Castelein H, Gulick T, Declercq PE, Mannaerts GP, Moore DD & Baes MI 1994 The peroxisome proliferator activated receptor regulates malic enzyme gene expression. Journal of Biological Chemistry 269 26754-26758.
8. CheathamWW 2010 Peroxisome proliferator-activated receptor translational research and clinical experience. American Journal of Clinical Nutrition 91 262S-266S
9. Chui PC, Guan HP, Lehrke M & Lazar MA 2005 PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. Journal of Clinical Investigation 115 2244-2256
10. Cimmino M, Mion F, Goglia F, Minaire Y & Geloen A 1996 Demonstration of in vivo metabolic effects of 3,5-di-iodothyronine. Journal of Endocrinology 149 319-325
11. Collino M, Aragno M, Castiglia S, Miglio G, Tomasinelli C, Boccuzzi G, Thiemermann C & Fantozzi R 2010 Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. British Journal of Pharmacology 160 1892-1902
12. Dalen KT, Dahl T, Holter E, Arntsen B, Londos C, Sztalryd C & Nebb HI 2007 LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues. Biochimica et Biophysica Acta 1771 210-227.
13. Day CP 2006 From fat to inflammation. Gastroenterology 130 207-210.
14. Delerive P, Fruchart JC & Staels B 2001 Peroxisome proliferator-activated receptors in inflammation control. Journal of Endocrinology 169 453-459.
15. Ducharme NA & Bickel PE 2008 Lipid droplets in lipogenesis and lipolysis. Endocrinology 149 942-949
16. Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E & Sul HS 2007 Regulation of lipolysis in adipocytes. Annual Review of Nutrition 27 79-101.
17. Duval C, Muller M & Kersten S 2007 PPARalpha and dyslipidemia. Biochimica et Biophysica Acta 1771 961-971
18. Evans RM, Barish GD &Wang YX 2004 PPARs and the complex journey to obesity. Nature Medicine 10 355-361
19. Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ & Reitman ML 2003 Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. Journal of Biological Chemistry 278 34268-34276
20. Goglia F 2005 Biological effects of 3,5-diiodothyronine (T(2)). Biochemistry 70 164-172.
21. Grasselli E, Canesi L, Voci A, De Matteis R, Demori I, Fugassa E & Vergani L 2008 Effects of 3,5-diiodo-L-thyronine administration on the liver of high fat diet-fed rats. Experimental Biology and Medicine 233 549-557
22. Grasselli E, Voci A, Pesce C, Canesi L, Fugassa E, Gallo G & Vergani L 2010 PAT protein mRNA expression in primary rat hepatocytes: effects of exposure to fatty acids. International Journal of Molecular Medicine 25 505-512.
23. Grasselli E, Voci A, Canesi L, De Matteis R, Goglia F, Cioffi F, Fugassa E, Gallo G & Vergani L 2011a Direct effects of iodothyronines on excess fat storage in rat hepatocytes. Journal of Hepatology 54 1230-1236.
24. Grasselli E, Voci A, Canesi L, Goglia F, Ravera S, Panfoli I, Gallo G & Vergani L 2011b Non-receptor-mediated actions are responsible for the lipidlowering effects of iodothyronines in FaO rat hepatoma cells. Journal of Endocrinology 210 59-69.
25. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase
26. Hsu SM, Raine L & Fanger H 1981 Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemistry and Cytochemistry 29 577-580.
27. Jitrapakdee S, Slawik M, Medina-Gomez G, Campbell M, Wallace JC, Sethi JK, O'rahilly S & Vidal-Puig AJ 2005 The peroxisome proliferator-activated receptor-gamma regulates murine pyruvate carboxylase gene expression in vivo and in vitro. Journal of Biological Chemistry 280 27466-27476.
28. Jokinen EV, Landschulz KT, Wyne KL, Ho YK, Frykman PK & Hobbs HH 1994 Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. Journal of Biological Chemistry 269 26411-26418.
29. Kadereit B, Kumar P, Wang WJ, Miranda D, Snapp EL, Severina N, Torregroza I, Evans T & Silver DL 2008 Evolutionarily conserved gene family important for fat storage. PNAS 105 94-99.
30. Kapadia R, Yi JH & Vemuganti R 2008 Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Frontiers in Bioscience 13 1813-1826.
31. Kershaw EE, Schupp M, Guan HP, Gardner NP, Lazar MA & Flier JS 2007 PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. American Journal of Physiology. Endocrinology and Metabolism 293 E1736-E1745.
32. Kimmel AR, Brasaemle DL, McAndrews-Hill M, Sztalryd C & Londos C 2010 Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins. Journal of Lipid Research 51 468-471.
33. Koopman R, Schaart G & Hesselink MK 2001 Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochemistry and Cell Biology 116 63-68
34. Lanni A, Moreno M, Lombardi A & Goglia F 1994 Rapid stimulation in vitro of rat liver cytochrome oxidase activity by 3,5-diiodo-L-thyronine and by 3,30-diiodo-L-thyronine. Molecular and Cellular Endocrinology 99 89-94.
35. Lanni A, Moreno M, Lombardi A, de Lange P, Silvestri E, Ragni M, Farina P, Baccari GC, Fallahi P, Antonelli A et al. 2005 3,5-Diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB Journal 19 1552-1554.
36. Lombardi A, Lanni A, Moreno M, Brand MD & Goglia F 1998 Effect of 3,5-di-iodo-L-thyronine on the mitochondrial energy-transduction apparatus. Biochemical Journal 330 521-526.
37. Lombardi A, Lanni A, de Lange P, Silvestri E, Grasso P, Senese R, Goglia F & Moreno M 2007 Acute administration of 3,5-diiodo-L-thyronine to hypothyroid rats affects bioenergetic parameters in rat skeletal muscle mitochondria. FEBS Letters 581 5911-5916.
38. Magnusson B, Asp L, Bostrom P, Ruiz M, Stillemark-Billton P, Linden D, Boren J & Olofsson SO 2006 Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology 26 1566-1571.
39. Mollica MP, Lionetti L, Moreno M, Lombardi A, de Lange P, Antonelli A, Lanni A, Cavaliere G, Barletta A & Goglia F 2009 3,5-Diiodo-L-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. Journal of Hepatology 51 363-370.
40. Moreno M, Lanni A, Lombardi A & Goglia F 1997 How the thyroid controls metabolism in the rat: different roles for triiodothyronine and diiodothyronines. Journal of Physiology 505 529-538.
41. Motojima K, Passilly P, Peters JM, Gonzalez FJ & Latruffe N 1998 Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. Journal of Biological Chemistry 273 16710-16714.
42. Musso G, Gambino R & Cassader M 2009 Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Progress in Lipid Research 48 1-26.
43. Nishikawa M, Inada M, Naito K, Ishii H, Tanaka K, Mashio Y & Imura H 1983 Serum concentrations of 3, 30-diiodothyronine, 30, 50-diiodothyronine, and 3, 5-diiodothyronine in altered thyroid states. Endocrinologia Japonica 30 167-172.
44. Olofsson SO, Bostrom P, Andersson L, Rutberg M, Perman J & Boren J 2009 Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochimica et Biophysica Acta 1791 448-458.
45. Ong KT, Mashek MT, Bu SY, Greenberg AS & Mashek DG 2011 Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology 53 116-126.
46. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29 e45.
47. Pyper SR, Viswakarma N, Yu S & Reddy JK 2010 PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nuclear Receptor Signaling 8 e002.
48. Reddy JK 2001 Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. American Journal of Physiology. Gastrointestinal and Liver Physiology 281 G1333-G1339.
49. Reid BN, Ables GP, Otlivanchik OA, Schoiswohl G, Zechner R, BlanerWS, Goldberg IJ, Schwabe RF, Chua SC Jr & Huang LS 2008 Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. Journal of Biological Chemistry 283 13087-13099.
50. Rogue A, Renaud MP, Claude N, Guillouzo A & Spire C 2011 Comparative gene expression profiles induced by PPARgamma and PPARalpha/gamma agonists in rat hepatocytes. Toxicology and Applied Pharmacology 254 18-31.
51. Romero Mdel M, Fernández-López JA, Esteve M & Alemany M 2009 Oleoyl-oestrone inhibits lipogenic, but maintains thermogenic, gene expression of brown adipose tissue in overweight rats. Bioscience Reports 29 237-243
52. Schadinger SE, Bucher NL, Schreiber BM & Farmer SR 2005 PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. American Journal of Physiology. Endocrinology and Metabolism 288 E1195-E1205
53. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, Staels B & Auwerx J 1996 PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO Journal 15 5336-5348.
54. Serviddio G, Bellanti F, Tamborra R, Rollo T, Romano AD, Giudetti AM, Capitanio N, Petrella A, Vendemiale G & Altomare E 2008 Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model. European Journal of Clinical Investigation 38 245-252.
55. Silvestri E, Cioffi F, Glinni D, Ceccarelli M, Lombardi A, de Lange P, Chambery A, Severino V, Lanni A, Goglia F et al. 2010 Pathways affected by 3,5-diiodo-L-thyronine in liver of high fat-fed rats: evidence from two-dimensional electrophoresis, blue-native PAGE, and mass spectrometry. Molecular Biosystems 6 2256-2271.
56. Spann NJ, Kang S, Li AC, Chen AZ, Newberry EP, Davidson NO, Hui ST & Davis RA 2006 Coordinate transcriptional repression of liver fatty acidbinding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis. Journal of Biological Chemistry 281 33066-33077.
57. Straus DS & Glass CK 2007 Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends in Immunology 28 551-558.
58. Sun J, Zhang C, Chen H, Fang X, Jin Q, Chen D, Shi X & Du Y 2010 Two novel SNPs in coding region of the caprine fat-inducing transcript gene and their association with growth traits. Molecular Biology Reports 37 485-490.
59. Unger RH, Clark GO, Scherer PE & Orci L 2010 Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochimica et Biophysica Acta 1801 209-214.
60. Vance JE & Vance DE 1990 Lipoprotein assembly and secretion by hepatocytes. Annual Review of Nutrition 10 337-356.
61. Vergani L, Lanza C, Rivaro P, Abelmoschi ML, Shyti G, Veneselli E, Minniti G, Grasselli E, Canesi L & Voci A 2011 Metals, metallothioneins and oxidative stress in blood of autistic children. Research in Autism Spectrum Disorders 5 286-293.
62. Viswakarma N, Jia Y, Bai L, Vluggens A, Borensztajn J, Xu J & Reddy JK 2010 Coactivators in PPAR-regulated gene expression. PPAR Research 2010
63. Wanders RJ, Ferdinandusse S, Brites P & Kemp S 2010 Peroxisomes, lipid metabolism and lipotoxicity. Biochimica et Biophysica Acta 1801 272-280.
64. Wang H, Wei E, Quiroga AD, Sun X, Touret N & Lehner R 2010 Altered lipid droplet dynamics in hepatocytes lacking triacylglycerol hydrolase expression. Molecular Biology of the Cell 21 1991-2000.
65. Wolins NE, Rubin B & Brasaemle DL 2001 TIP47 associates with lipid droplets. Journal of Biological Chemistry 276 5101-5108.
66. Yamaguchi T, Matsushita S, Motojima K, Hirose F & Osumi T 2006 MLDP, a novel PAT family protein localized to lipid droplets and enriched in the heart, is regulated by peroxisome proliferator-activated receptor alpha. Journal of Biological Chemistry 281 14232-14240.
67. Zechner R, Kienesberger PC, Haemmerle G, Zimmermann R & Lass A 2009 Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. Journal of Lipid Research 50 3-21.
68. Zimmermann R, Lass A, Haemmerle G & Zechner R 2009 Fate of fat: the role of adipose triglyceride lipase in lipolysis. Biochimica et Biophysica Acta 1791 494-500.
69. Zivkovic AM, German JB & Sanyal AJ 2007 Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. American Journal of Clinical Nutrition 86 285-300.